This article examines the evolution of competition law cases in the context of the Indian pharmaceutical industry. The Competition Commission of India and Competition Appellate Tribunal of India are two of the most important emerging institutions in guiding firm behaviour and competition in modern India. Together with other institutions, it is important that their activities are guided by economic reasoning, which for the most part, they seem to be doing. This article was a short attempt in highlighting their status as of today. Our data and analysis, which for the first time assembles historical information and demonstrates heterogeneities in behaviours and outcomes therein, should provide a starting point to conduct more fine-grained analysis on the evolution of competition law cases in the Indian pharmaceutical sector and more broadly across the economy.

中文翻译：

---

印度医药市场竞争法何去何从？：来自CCI和COMPAT仲裁数据的证据

本文考察了印度制药业背景下竞争法案例的演变。印度竞争委员会和印度竞争上诉法庭是指导现代印度企业行为和竞争的两个最重要的新兴机构。与其他机构一起，重要的是他们的活动以经济推理为指导，在大多数情况下，他们似乎正在这样做。这篇文章是一个简短的尝试，旨在突出他们今天的地位。我们的数据和分析首次汇集了历史信息并展示了其中行为和结果的异质性，